首页 > 最新文献

Global Health Research and Policy最新文献

英文 中文
Childhood immunization uptake determinants in Kinshasa, Democratic Republic of the Congo: ordered regressions to assess timely infant vaccines administered at birth and 6-weeks. 刚果民主共和国金沙萨儿童免疫接种决定因素:有序回归以评估出生时和6周内及时接种的婴儿疫苗。
IF 4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-12-06 DOI: 10.1186/s41256-023-00338-7
Alix Boisson-Walsh, Peyton Thompson, Bruce Fried, Christopher Michael Shea, Patrick Ngimbi, Fidéle Lumande, Martine Tabala, Melchior Mwandagalirwa Kashamuka, Pélagie Babakazo, Marisa Elaine Domino, Marcel Yotebieng

Background: Despite global efforts to reduce preventable childhood illness by distributing infant vaccines, immunization coverage in sub-Saharan African settings remains low. Further, timely administration of vaccines at birth-tuberculosis (Bacille Calmette-Guérin [BCG]) and polio (OPV0)-remains inconsistent. As countries such as Democratic Republic of the Congo (DRC) prepare to add yet another birth-dose vaccine to their immunization schedule, this study aims to improve current and future birth-dose immunization coverage by understanding the determinants of infants receiving vaccinations within the national timeframe.

Methods: The study used two ordered regression models to assess barriers to timely BCG and first round of the hepatitis B (HepB3) immunization series across multiple time points using the Andersen Behavioral Model to conceptualize determinants at various levels. The assessment leveraged survey data collected during a continuous quality improvement study (NCT03048669) conducted in 105 maternity centers throughout Kinshasa Province, DRC. The final sample included 2398 (BCG analysis) and 2268 (HepB3 analysis) women-infant dyads living with HIV.

Results: Between 2016 and 2020, 1981 infants (82.6%) received the BCG vaccine, and 1551 (68.4%) received the first dose of HepB3 vaccine. Of those who received the BCG vaccine, 26.3%, 43.5%, and 12.8% received BCG within 24 h, between one and seven days, and between one and 14 weeks, respectively. Of infants who received the HepB3 vaccine, 22.4% received it within six weeks, and 46% between six and 14 weeks of life. Many factors were positively associated with BCG uptake, including higher maternal education, household wealth, higher facility general readiness score, and religious-affiliated facility ownership. The factors influencing HepB3 uptake included older maternal age, higher education level, household wealth, transport by taxi to a facility, higher facility general and immunization readiness scores, and religious-affiliated facility ownership.

Conclusions: This study demonstrated that the study participants' uptake of vaccines was consistent with the country average, but not in a timely manner. Various factors were associated with timely uptake of BCG and HepB3 vaccines. These findings suggest that investment to strengthen the vaccine delivery system might improve timely vaccine uptake and equity in vaccine coverage.

背景:尽管全球努力通过分发婴儿疫苗来减少可预防的儿童疾病,但撒哈拉以南非洲地区的免疫覆盖率仍然很低。此外,在出生时及时接种结核病(卡介苗)和脊髓灰质炎(OPV0)疫苗仍然不一致。由于刚果民主共和国(DRC)等国家准备在其免疫计划中增加另一种出生剂量疫苗,本研究旨在通过了解婴儿在国家时间框架内接受疫苗接种的决定因素,提高当前和未来的出生剂量免疫覆盖率。方法:该研究使用两个有序回归模型评估跨多个时间点及时接种卡介苗和第一轮乙型肝炎(HepB3)免疫系列的障碍,使用Andersen行为模型概念化不同水平的决定因素。该评估利用了在刚果民主共和国金沙萨省105个妇产中心开展的持续质量改进研究(NCT03048669)中收集的调查数据。最终样本包括2398例(卡介苗分析)和2268例(HepB3分析)感染艾滋病毒的母婴双体。结果:2016 - 2020年,1981例(82.6%)婴儿接种了卡介苗,1551例(68.4%)接种了HepB3疫苗。在接种卡介苗的人群中,分别有26.3%、43.5%和12.8%的人在24小时内、1至7天内和1至14周内接种了卡介苗。在接种HepB3疫苗的婴儿中,22.4%在6周内接种,46%在6至14周之间接种。许多因素与BCG摄取呈正相关,包括较高的母亲教育程度、家庭财富、较高的设施一般准备得分和宗教附属设施所有权。影响HepB3吸收的因素包括母亲年龄较大、受教育程度较高、家庭财富、乘坐出租车前往设施、较高的设施一般和免疫准备得分以及宗教附属设施所有权。结论:本研究表明,研究参与者的疫苗接种率与全国平均水平一致,但并不及时。多种因素与卡介苗和HepB3疫苗的及时接种有关。这些发现表明,加强疫苗提供系统的投资可能会改善疫苗的及时吸收和疫苗覆盖的公平性。
{"title":"Childhood immunization uptake determinants in Kinshasa, Democratic Republic of the Congo: ordered regressions to assess timely infant vaccines administered at birth and 6-weeks.","authors":"Alix Boisson-Walsh, Peyton Thompson, Bruce Fried, Christopher Michael Shea, Patrick Ngimbi, Fidéle Lumande, Martine Tabala, Melchior Mwandagalirwa Kashamuka, Pélagie Babakazo, Marisa Elaine Domino, Marcel Yotebieng","doi":"10.1186/s41256-023-00338-7","DOIUrl":"10.1186/s41256-023-00338-7","url":null,"abstract":"<p><strong>Background: </strong>Despite global efforts to reduce preventable childhood illness by distributing infant vaccines, immunization coverage in sub-Saharan African settings remains low. Further, timely administration of vaccines at birth-tuberculosis (Bacille Calmette-Guérin [BCG]) and polio (OPV0)-remains inconsistent. As countries such as Democratic Republic of the Congo (DRC) prepare to add yet another birth-dose vaccine to their immunization schedule, this study aims to improve current and future birth-dose immunization coverage by understanding the determinants of infants receiving vaccinations within the national timeframe.</p><p><strong>Methods: </strong>The study used two ordered regression models to assess barriers to timely BCG and first round of the hepatitis B (HepB3) immunization series across multiple time points using the Andersen Behavioral Model to conceptualize determinants at various levels. The assessment leveraged survey data collected during a continuous quality improvement study (NCT03048669) conducted in 105 maternity centers throughout Kinshasa Province, DRC. The final sample included 2398 (BCG analysis) and 2268 (HepB3 analysis) women-infant dyads living with HIV.</p><p><strong>Results: </strong>Between 2016 and 2020, 1981 infants (82.6%) received the BCG vaccine, and 1551 (68.4%) received the first dose of HepB3 vaccine. Of those who received the BCG vaccine, 26.3%, 43.5%, and 12.8% received BCG within 24 h, between one and seven days, and between one and 14 weeks, respectively. Of infants who received the HepB3 vaccine, 22.4% received it within six weeks, and 46% between six and 14 weeks of life. Many factors were positively associated with BCG uptake, including higher maternal education, household wealth, higher facility general readiness score, and religious-affiliated facility ownership. The factors influencing HepB3 uptake included older maternal age, higher education level, household wealth, transport by taxi to a facility, higher facility general and immunization readiness scores, and religious-affiliated facility ownership.</p><p><strong>Conclusions: </strong>This study demonstrated that the study participants' uptake of vaccines was consistent with the country average, but not in a timely manner. Various factors were associated with timely uptake of BCG and HepB3 vaccines. These findings suggest that investment to strengthen the vaccine delivery system might improve timely vaccine uptake and equity in vaccine coverage.</p>","PeriodicalId":52405,"journal":{"name":"Global Health Research and Policy","volume":"8 1","pages":"50"},"PeriodicalIF":4.0,"publicationDate":"2023-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10698958/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138500100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Economic costs of alcohol consumption in Thailand, 2021 2021 年泰国酒精消费的经济成本
IF 8.7 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-12-01 DOI: 10.1186/s41256-023-00335-w
Chaisiri Luangsinsiri, S. Youngkong, Usa Chaikledkaew, O. Pattanaprateep, M. Thavorncharoensap
{"title":"Economic costs of alcohol consumption in Thailand, 2021","authors":"Chaisiri Luangsinsiri, S. Youngkong, Usa Chaikledkaew, O. Pattanaprateep, M. Thavorncharoensap","doi":"10.1186/s41256-023-00335-w","DOIUrl":"https://doi.org/10.1186/s41256-023-00335-w","url":null,"abstract":"","PeriodicalId":52405,"journal":{"name":"Global Health Research and Policy","volume":" 2","pages":""},"PeriodicalIF":8.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138614419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strengthening the primary health care for non-communicable disease prevention and control in the post-pandemic period: a perspective from China. 大流行后时期加强初级卫生保健以预防和控制非传染性疾病:来自中国的视角。
IF 4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-11-29 DOI: 10.1186/s41256-023-00336-9
Zhangyang Pan, Jing Wu, Yunguo Liu

Non-communicable diseases (NCDs) have become the leading cause of deaths in China and many other countries worldwide. To call for actions in strengthening primary health care (PHC) and accelerate NCD prevention and control in the post-pandemic era in China, the 2023 Duke Kunshan Health Forum focused on innovative approaches and lessons learned during the pandemic that can be applied in addressing NCD challenges. In this article we summarize key points discussed by the participants in three areas: PHC as the foundation and ultimate solution for NCD prevention and control, post-pandemic opportunities to accelerate the NCD program with innovative approaches, and an action framework proposed by the Forum collaborators to address remaining challenges and achieve NCD control objectives in China. The core of the suggested action framework is to offer people-centered, lifetime, comprehensive, continued, and quality NCD prevention and control services, which rely on an integrated healthcare system connecting the primary, secondary, and tertiary levels of care. To achive this objective, six interconnected actions are recommended in the framework: prioritizing and integrating NCD in PHC and Universal Health Coverage (UHC) framework, engaging multiple stakeholders, directing resources to PHC for quality NCD services, leveraging advantages of new technology, encouraging the use of PHC and improving services, and strengthening best practice sharing.

非传染性疾病(NCDs)已成为中国和世界上许多其他国家的主要死亡原因。为呼吁中国在大流行后时代加强初级卫生保健,加快非传染性疾病防控,2023年昆山杜克大学卫生论坛重点讨论了大流行期间可用于应对非传染性疾病挑战的创新方法和经验教训。本文总结了与会者在以下三个方面讨论的要点:初级保健作为非传染性疾病预防和控制的基础和最终解决方案,大流行后以创新方法加速非传染性疾病规划的机会,以及论坛合作者提出的应对剩余挑战和实现中国非传染性疾病控制目标的行动框架。建议的行动框架的核心是提供以人为本、终身、全面、持续和高质量的非传染性疾病预防和控制服务,这依赖于连接初级、二级和三级保健的综合卫生保健系统。为实现这一目标,框架中建议采取六项相互关联的行动:优先考虑非传染性疾病并将其纳入初级保健和全民健康覆盖框架,让多个利益攸关方参与进来,将资源用于初级保健以提供高质量的非传染性疾病服务,利用新技术的优势,鼓励使用初级保健并改善服务,以及加强最佳做法分享。
{"title":"Strengthening the primary health care for non-communicable disease prevention and control in the post-pandemic period: a perspective from China.","authors":"Zhangyang Pan, Jing Wu, Yunguo Liu","doi":"10.1186/s41256-023-00336-9","DOIUrl":"10.1186/s41256-023-00336-9","url":null,"abstract":"<p><p>Non-communicable diseases (NCDs) have become the leading cause of deaths in China and many other countries worldwide. To call for actions in strengthening primary health care (PHC) and accelerate NCD prevention and control in the post-pandemic era in China, the 2023 Duke Kunshan Health Forum focused on innovative approaches and lessons learned during the pandemic that can be applied in addressing NCD challenges. In this article we summarize key points discussed by the participants in three areas: PHC as the foundation and ultimate solution for NCD prevention and control, post-pandemic opportunities to accelerate the NCD program with innovative approaches, and an action framework proposed by the Forum collaborators to address remaining challenges and achieve NCD control objectives in China. The core of the suggested action framework is to offer people-centered, lifetime, comprehensive, continued, and quality NCD prevention and control services, which rely on an integrated healthcare system connecting the primary, secondary, and tertiary levels of care. To achive this objective, six interconnected actions are recommended in the framework: prioritizing and integrating NCD in PHC and Universal Health Coverage (UHC) framework, engaging multiple stakeholders, directing resources to PHC for quality NCD services, leveraging advantages of new technology, encouraging the use of PHC and improving services, and strengthening best practice sharing.</p>","PeriodicalId":52405,"journal":{"name":"Global Health Research and Policy","volume":"8 1","pages":"49"},"PeriodicalIF":4.0,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685497/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138464309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global health collaborative research: beyond mandatory collaboration to mandatory authorship. 全球卫生合作研究:从强制合作到强制署名。
IF 4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-11-22 DOI: 10.1186/s41256-023-00334-x
Wongani John Nyangulu

Collaborative research between the global north and global south is common and growing in number. Due to inability of local governments to fund research, global north actors provide the bulk of research funding. While providing mutual benefits, global collaborative research projects are far from ideal. In this paper, we review the authorship discrepancies in global collaborative research, discuss preventive measures in place and their shortfalls, and recommend an intervention to address the problem. Malawi research guidelines recommend collaboration between foreign and local researchers in locally conducted research. However, there is no provision requiring joint authorship in final published papers. Journal recommendations on authorship criteria exist, but they can disadvantage low- and middle-income country researchers in collaborative projects because of exclusionary interpretations of guidelines. For example, the requirement for authors to make substantial contributions to conception or design of the work may favor research grant holders, often from the global north. Systematic and holistic changes proposed to address power asymmetries at the core of the problem have been proposed. However, these proposals may take a long time to produce change. Ad interim, local institutions can take more direct action to address inequalities by establishing offices of research integrity to enforce mandates to increase opportunities for authorship in collaborative research.

全球北方和全球南方之间的合作研究是普遍的,而且越来越多。由于地方政府无力资助研究,全球北方参与者提供了大部分研究资金。在提供互惠互利的同时,全球合作研究项目远非理想。在本文中,我们回顾了全球合作研究中的作者差异,讨论了现有的预防措施及其不足之处,并提出了解决问题的干预措施。马拉维研究指南建议外国和当地研究人员在当地进行的研究中进行合作。然而,在最终发表的论文中没有要求共同作者的规定。关于作者标准的期刊建议是存在的,但是由于对指南的排斥性解释,它们可能使中低收入国家的研究人员在合作项目中处于不利地位。例如,要求作者对工作的概念或设计做出重大贡献可能有利于研究资助的持有者,这些人通常来自北半球。已经提出了系统和整体的变革,以解决问题的核心——权力不对称。然而,这些建议可能需要很长时间才能产生变化。在此期间,地方机构可以采取更直接的行动,通过建立研究诚信办公室来解决不平等问题,以执行授权,增加合作研究中作者的机会。
{"title":"Global health collaborative research: beyond mandatory collaboration to mandatory authorship.","authors":"Wongani John Nyangulu","doi":"10.1186/s41256-023-00334-x","DOIUrl":"10.1186/s41256-023-00334-x","url":null,"abstract":"<p><p>Collaborative research between the global north and global south is common and growing in number. Due to inability of local governments to fund research, global north actors provide the bulk of research funding. While providing mutual benefits, global collaborative research projects are far from ideal. In this paper, we review the authorship discrepancies in global collaborative research, discuss preventive measures in place and their shortfalls, and recommend an intervention to address the problem. Malawi research guidelines recommend collaboration between foreign and local researchers in locally conducted research. However, there is no provision requiring joint authorship in final published papers. Journal recommendations on authorship criteria exist, but they can disadvantage low- and middle-income country researchers in collaborative projects because of exclusionary interpretations of guidelines. For example, the requirement for authors to make substantial contributions to conception or design of the work may favor research grant holders, often from the global north. Systematic and holistic changes proposed to address power asymmetries at the core of the problem have been proposed. However, these proposals may take a long time to produce change. Ad interim, local institutions can take more direct action to address inequalities by establishing offices of research integrity to enforce mandates to increase opportunities for authorship in collaborative research.</p>","PeriodicalId":52405,"journal":{"name":"Global Health Research and Policy","volume":"8 1","pages":"48"},"PeriodicalIF":4.0,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664688/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138296514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Awareness of and participation in mass drug administration programs used for onchocerciasis control in the Atwima Nwabiagya North District, Ghana. 加纳Atwima Nwabiagya北区对用于控制盘尾丝虫病的大规模药物管理规划的认识和参与。
IF 4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-11-14 DOI: 10.1186/s41256-023-00331-0
Francis Adjei Osei, Sam Kofi Tekyi Newton, Isaac Nyanor, Eugene Osei-Yeboah, Evans Xorse Amuzu, Nicholas Karikari Mensah, Obed Ofori Nyarko, Ernest Amanor, Samuel Frimpong Odoom, Suraj Yawnumah Abubakar, Mathias Dongyele, Aliyu Mohammed, Ofeibea Asare, Stephanie Boadi, Peter Furu, Dan Wolf Meyrowitsch, Ellis Owusu-Dabo

Background: Studies on Mass drug administration (MDA) in Ghana targeting various diseases, have mostly focused on factors that affect coverage and compliance to MDA with limited focus on evidence regarding awareness and community perception of the program. Therefore, this study sought to provide empirical evidence on the knowledge of onchocerciasis, and awareness of and participation in the MDA among community members.

Methods: A community-based cross-sectional survey was conducted from August to October 2019 in communities within the Atwima Nwabiagya North District, Ghana. Data was collected from 2,008 respondents. Bivariate and multivariate logistic regression analyses were performed to measure the associations between socio-demographics, having heard of onchocerciasis and its prevention, and levels of awareness of the MDA program.

Results: A total of 1268 respondents (63.2%) were aware of the MDA program. The majority ofMost respondents (74.4%) were of the view that the information given about the program was not enough and 45.4% of the respondents had no idea about the relevance of the MDA program. Respondents who had ever heard about onchocerciasis prevention and persons who had previously participated in the MDA program were more likely to be aware of the MDA program during implementation (AOR = 2.32; 95% CI 1.79-3.01 and AOR = 9.31; 95% CI 7.06-12.26, respectively).

Conclusions: We observed a significant association between being aware of MDA campaigns and knowledge of onchocerciasis and its preventive methods, and participation in previous MDA campaigns. We recommend intensification and improvement of prevention campaigns regarding the onchocerciasis MDA program as key to ensuring increased MDA program participation.

背景:关于加纳针对各种疾病的大规模药物管理(MDA)的研究主要集中在影响MDA覆盖面和依从性的因素上,而对有关该计划的认识和社区看法的证据关注有限。因此,本研究试图提供关于盘尾丝虫病知识的经验证据,以及社区成员对盘尾丝虫病预防计划的认识和参与。方法:2019年8月至10月在加纳Atwima Nwabiagya北区的社区进行了一项基于社区的横断面调查。数据收集自2008名受访者。进行双变量和多变量logistic回归分析,以测量社会人口统计学、听说过盘尾丝虫病及其预防以及对MDA计划的认识水平之间的关联。结果:1268名被调查者(63.2%)知晓MDA计划。大多数受访者(74.4%)认为该计划所提供的信息不够,45.4%的受访者不知道MDA计划的相关性。曾经听说过盘尾丝虫病预防的应答者和曾经参加过MDA项目的应答者在实施过程中更有可能了解MDA项目(AOR = 2.32;95% CI 1.79 ~ 3.01, AOR = 9.31;95% CI分别为7.06-12.26)。结论:我们观察到意识到MDA运动和盘尾丝虫病及其预防方法的知识之间的显著关联,并参与以前的MDA运动。我们建议加强和改进盘尾丝虫病MDA项目的预防运动,这是确保增加MDA项目参与的关键。
{"title":"Awareness of and participation in mass drug administration programs used for onchocerciasis control in the Atwima Nwabiagya North District, Ghana.","authors":"Francis Adjei Osei, Sam Kofi Tekyi Newton, Isaac Nyanor, Eugene Osei-Yeboah, Evans Xorse Amuzu, Nicholas Karikari Mensah, Obed Ofori Nyarko, Ernest Amanor, Samuel Frimpong Odoom, Suraj Yawnumah Abubakar, Mathias Dongyele, Aliyu Mohammed, Ofeibea Asare, Stephanie Boadi, Peter Furu, Dan Wolf Meyrowitsch, Ellis Owusu-Dabo","doi":"10.1186/s41256-023-00331-0","DOIUrl":"10.1186/s41256-023-00331-0","url":null,"abstract":"<p><strong>Background: </strong>Studies on Mass drug administration (MDA) in Ghana targeting various diseases, have mostly focused on factors that affect coverage and compliance to MDA with limited focus on evidence regarding awareness and community perception of the program. Therefore, this study sought to provide empirical evidence on the knowledge of onchocerciasis, and awareness of and participation in the MDA among community members.</p><p><strong>Methods: </strong>A community-based cross-sectional survey was conducted from August to October 2019 in communities within the Atwima Nwabiagya North District, Ghana. Data was collected from 2,008 respondents. Bivariate and multivariate logistic regression analyses were performed to measure the associations between socio-demographics, having heard of onchocerciasis and its prevention, and levels of awareness of the MDA program.</p><p><strong>Results: </strong>A total of 1268 respondents (63.2%) were aware of the MDA program. The majority ofMost respondents (74.4%) were of the view that the information given about the program was not enough and 45.4% of the respondents had no idea about the relevance of the MDA program. Respondents who had ever heard about onchocerciasis prevention and persons who had previously participated in the MDA program were more likely to be aware of the MDA program during implementation (AOR = 2.32; 95% CI 1.79-3.01 and AOR = 9.31; 95% CI 7.06-12.26, respectively).</p><p><strong>Conclusions: </strong>We observed a significant association between being aware of MDA campaigns and knowledge of onchocerciasis and its preventive methods, and participation in previous MDA campaigns. We recommend intensification and improvement of prevention campaigns regarding the onchocerciasis MDA program as key to ensuring increased MDA program participation.</p>","PeriodicalId":52405,"journal":{"name":"Global Health Research and Policy","volume":"8 1","pages":"47"},"PeriodicalIF":4.0,"publicationDate":"2023-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644529/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"107592780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adaptation of the CUGH global health competency framework in the Chinese context: a mixed-methods study. CUGH全球健康能力框架在中国背景下的适应性:一项混合方法研究。
IF 4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-11-02 DOI: 10.1186/s41256-023-00327-w
Wei Ding, Yayi Guan, Bernadette Peterhans, Axel Hoffmann, Xiao-Nong Zhou

Background: In 2014, the Consortium of Universities for Global Health (CUGH) developed a global health competency framework and called for its validation. Given China's increasing engagement in global health over the past decade, there is a need for a tailored competency framework to enhance the capacity of its workforce. This study aimed to localize the CUGH global health framework within the Chinese context, offering guidance to public health professionals in China to bolster their capabilities for international endeavors.

Methods: Employing a modified Delphi consultation approach, this study adapted the CUGH global health competency framework through three consultation rounds and a panel discussion. A questionnaire employing a five-point Likert scale was developed to gather opinions from 37 experts on the significance and feasibility of each competency within the Chinese setting. Profiling information, judgment criteria, and familiarity with each competency were collected to assess experts' authority levels. Furthermore, a priority survey was administered to 51 experts to identify key competencies and provide recommendations for bolstering the capabilities of China's public health professionals. Data analysis was performed using Microsoft Excel.

Results: The adapted framework comprises 10 domains and 37 competencies including: 1. Global Burden of Disease; 2. Social-economic, Environmental and Behavioral Determinants of Health; 3. The Impact of Globalization on Population Health, Health Systems, and Healthcare; 4. Major Global health initiatives and efforts; 5. Ethics, Health Equity and Social Justice; 6. Sociocultural, Political Awareness and Policy Promotion; 7. Personal Competencies and Professional Practice; 8. Capacity strengthening; 9. Collaboration, Partnering and Communication; 10. Programme Management. The priority survey underscored Domain 9, 10, and 4 as the foremost concern for Chinese public health professionals, urging active learning, critical thinking, open communication, experiential learning, and case-based studies. Institutions were advised to enhance their capacity, foster partnerships, and discern China's distinct role in the global health arena.

Conclusions: This study adapted the CUGH framework within the Chinese context, evaluating the significance and feasibility of each competency. The adapted framework can serve as a tool for developing global health curricula and delineating roles for Chinese public health professionals. To ensure contextual compatibility, testing of the framework with diverse public health professionals is recommended, enabling precise refinement of competencies based on empirical results.

背景:2014年,全球卫生大学联盟(CUGH)制定了一个全球卫生能力框架,并要求对其进行验证。鉴于中国在过去十年中越来越多地参与全球卫生,有必要制定一个量身定制的能力框架来提高其劳动力的能力。本研究旨在将CUGH全球卫生框架在中国背景下本地化,为中国的公共卫生专业人员提供指导,以增强他们的国际努力能力。方法:采用改进的德尔菲咨询方法,本研究通过三轮咨询和小组讨论对CUGH全球健康能力框架进行了调整。采用五点Likert量表编制了一份问卷,收集了37位专家对每种能力在中国环境中的重要性和可行性的意见。收集分析信息、判断标准和对每种能力的熟悉程度,以评估专家的权威级别。此外,还对51名专家进行了优先调查,以确定关键能力,并为提高中国公共卫生专业人员的能力提供建议。使用Microsoft Excel进行数据分析。结果:调整后的框架包括10个领域和37项能力,包括:1。全球疾病负担;2.健康的社会经济、环境和行为决定因素;3.全球化对人口健康、卫生系统和医疗保健的影响;4.全球重大卫生倡议和努力;5.伦理、健康公平和社会公正;6.社会文化、政治意识和政策宣传;7.个人能力和专业实践;8.加强能力;9.协作、伙伴关系和沟通;10.方案管理。优先调查强调,领域9、10和4是中国公共卫生专业人员最关心的问题,敦促积极学习、批判性思维、开放交流、体验式学习和基于案例的研究。建议各机构加强能力,促进伙伴关系,并认识到中国在全球卫生领域的独特作用。结论:本研究将CUGH框架应用于中国背景下,评估了每种能力的重要性和可行性。调整后的框架可以作为制定全球卫生课程和界定中国公共卫生专业人员角色的工具。为了确保上下文兼容性,建议与不同的公共卫生专业人员一起测试该框架,从而能够根据经验结果精确完善能力。
{"title":"Adaptation of the CUGH global health competency framework in the Chinese context: a mixed-methods study.","authors":"Wei Ding, Yayi Guan, Bernadette Peterhans, Axel Hoffmann, Xiao-Nong Zhou","doi":"10.1186/s41256-023-00327-w","DOIUrl":"10.1186/s41256-023-00327-w","url":null,"abstract":"<p><strong>Background: </strong>In 2014, the Consortium of Universities for Global Health (CUGH) developed a global health competency framework and called for its validation. Given China's increasing engagement in global health over the past decade, there is a need for a tailored competency framework to enhance the capacity of its workforce. This study aimed to localize the CUGH global health framework within the Chinese context, offering guidance to public health professionals in China to bolster their capabilities for international endeavors.</p><p><strong>Methods: </strong>Employing a modified Delphi consultation approach, this study adapted the CUGH global health competency framework through three consultation rounds and a panel discussion. A questionnaire employing a five-point Likert scale was developed to gather opinions from 37 experts on the significance and feasibility of each competency within the Chinese setting. Profiling information, judgment criteria, and familiarity with each competency were collected to assess experts' authority levels. Furthermore, a priority survey was administered to 51 experts to identify key competencies and provide recommendations for bolstering the capabilities of China's public health professionals. Data analysis was performed using Microsoft Excel.</p><p><strong>Results: </strong>The adapted framework comprises 10 domains and 37 competencies including: 1. Global Burden of Disease; 2. Social-economic, Environmental and Behavioral Determinants of Health; 3. The Impact of Globalization on Population Health, Health Systems, and Healthcare; 4. Major Global health initiatives and efforts; 5. Ethics, Health Equity and Social Justice; 6. Sociocultural, Political Awareness and Policy Promotion; 7. Personal Competencies and Professional Practice; 8. Capacity strengthening; 9. Collaboration, Partnering and Communication; 10. Programme Management. The priority survey underscored Domain 9, 10, and 4 as the foremost concern for Chinese public health professionals, urging active learning, critical thinking, open communication, experiential learning, and case-based studies. Institutions were advised to enhance their capacity, foster partnerships, and discern China's distinct role in the global health arena.</p><p><strong>Conclusions: </strong>This study adapted the CUGH framework within the Chinese context, evaluating the significance and feasibility of each competency. The adapted framework can serve as a tool for developing global health curricula and delineating roles for Chinese public health professionals. To ensure contextual compatibility, testing of the framework with diverse public health professionals is recommended, enabling precise refinement of competencies based on empirical results.</p>","PeriodicalId":52405,"journal":{"name":"Global Health Research and Policy","volume":"8 1","pages":"46"},"PeriodicalIF":4.0,"publicationDate":"2023-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621075/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71429060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors associated with the utilization of diagnostic tools among countries with different income levels during the COVID-19 pandemic. 新冠肺炎大流行期间不同收入水平国家使用诊断工具的相关因素。
IF 4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-10-27 DOI: 10.1186/s41256-023-00330-1
Shuduo Zhou, Xiangning Feng, Yunxuan Hu, Jian Yang, Ying Chen, Jon Bastow, Zhi-Jie Zheng, Ming Xu

Background: Disparities in the utilization of essential medical products are a key factor contributing to inequality in health outcomes. We aimed to analyze the trends and influencing factors in using Coronavirus disease 2019 (COVID-19) diagnostic tools and disparities in countries with different income levels.

Methods: We conducted a cross-sectional study using open and publicly available data sources. Data were mainly collected from the Foundation for Innovative New Diagnostics, "Our World in Data," and the Global Burden of Disease databases. Negative binomial regression model and generalized linear mixed model were employed to investigate into five sets of factors associated with the usage of diagnostics: severity of COVID-19, socioeconomic status, health status, medical service capacity, and rigidity of response. Dominance analysis was utilized to compare the relative importance of these factors. The Blinder-Oaxaca decomposition was used to decompose the difference in the usage of diagnostics between countries.

Results: The total COVID-19 testing rate ranged from 5.13 to 22,386.63 per 1000 people from March 2020 to October 2022 and the monthly testing rate declined dramatically from January 2022 to October 2022 (52.37/1000 vs 5.91/1000).. The total testing rate was primarily associated with socioeconomic status (37.84%), with every 1 standard deviation (SD) increase in Gross Domestic Product per capita and the proportion of people aged ≥ 70, the total testing rate increased by 88% and 31%. And so is the medical service capacity (33.66%), with every 1 SD increase in health workforce density, the number increased by 38%. The monthly testing rate was primarily associated with socioeconomic status (34.72%) and medical service capacity (28.67%), and the severity of COVID-19 (21.09%). The average difference in the total testing rates between high-income and low-income countries was 2726.59 per 1000 people, and 2493.43 (91.45%) of the differences could be explained through the five sets of factors.

Conclusions: Redoubling the efforts, such as local manufacturing, regulatory reliance, and strengthening the community health workforce and laboratory capacity in low- and middle-income countries (LMICs) cannot be more significant for ensuring sustainable and equitable access to diagnostic tools during pandemic.

背景:基本医疗产品利用率的差异是造成健康结果不平等的一个关键因素。我们旨在分析2019冠状病毒病(新冠肺炎)诊断工具的使用趋势和影响因素,以及不同收入水平国家的差异。方法:我们使用公开和公开的数据来源进行了一项横断面研究。数据主要来自创新新诊断基金会、“我们的数据世界”和全球疾病负担数据库。采用负二项回归模型和广义线性混合模型研究了与诊断使用相关的五组因素:新冠肺炎的严重程度、社会经济状况、健康状况、医疗服务能力和反应的刚性。优势分析用于比较这些因素的相对重要性。Blinder Oaxaca分解用于分解国家之间诊断使用的差异。结果:2020年3月至2022年10月,新冠肺炎总检测率为每1000人5.13至22386.63,2022年1月至10月,月检测率大幅下降(52.37/1000比5.91/1000)。总检测率主要与社会经济状况相关(37.84%),人均国内生产总值和老年人口比例每增加1个标准差 ≥ 70,总检测率分别提高了88%和31%。医疗服务能力也是如此(33.66%),卫生劳动力密度每增加1 SD,人数就会增加38%。每月检测率主要与社会经济地位(34.72%)和医疗服务能力(28.67%)以及新冠肺炎的严重程度(21.09%)有关。高收入国家和低收入国家的总检测率平均差异为每1000人2726.59人,其中2493.43人(91.45%)的差异可以通过五组因素来解释。结论:加倍努力,如当地制造业、监管依赖,以及加强中低收入国家的社区卫生工作人员和实验室能力,对于确保在疫情期间可持续和公平地获得诊断工具来说,意义再大不过了。
{"title":"Factors associated with the utilization of diagnostic tools among countries with different income levels during the COVID-19 pandemic.","authors":"Shuduo Zhou, Xiangning Feng, Yunxuan Hu, Jian Yang, Ying Chen, Jon Bastow, Zhi-Jie Zheng, Ming Xu","doi":"10.1186/s41256-023-00330-1","DOIUrl":"10.1186/s41256-023-00330-1","url":null,"abstract":"<p><strong>Background: </strong>Disparities in the utilization of essential medical products are a key factor contributing to inequality in health outcomes. We aimed to analyze the trends and influencing factors in using Coronavirus disease 2019 (COVID-19) diagnostic tools and disparities in countries with different income levels.</p><p><strong>Methods: </strong>We conducted a cross-sectional study using open and publicly available data sources. Data were mainly collected from the Foundation for Innovative New Diagnostics, \"Our World in Data,\" and the Global Burden of Disease databases. Negative binomial regression model and generalized linear mixed model were employed to investigate into five sets of factors associated with the usage of diagnostics: severity of COVID-19, socioeconomic status, health status, medical service capacity, and rigidity of response. Dominance analysis was utilized to compare the relative importance of these factors. The Blinder-Oaxaca decomposition was used to decompose the difference in the usage of diagnostics between countries.</p><p><strong>Results: </strong>The total COVID-19 testing rate ranged from 5.13 to 22,386.63 per 1000 people from March 2020 to October 2022 and the monthly testing rate declined dramatically from January 2022 to October 2022 (52.37/1000 vs 5.91/1000).. The total testing rate was primarily associated with socioeconomic status (37.84%), with every 1 standard deviation (SD) increase in Gross Domestic Product per capita and the proportion of people aged ≥ 70, the total testing rate increased by 88% and 31%. And so is the medical service capacity (33.66%), with every 1 SD increase in health workforce density, the number increased by 38%. The monthly testing rate was primarily associated with socioeconomic status (34.72%) and medical service capacity (28.67%), and the severity of COVID-19 (21.09%). The average difference in the total testing rates between high-income and low-income countries was 2726.59 per 1000 people, and 2493.43 (91.45%) of the differences could be explained through the five sets of factors.</p><p><strong>Conclusions: </strong>Redoubling the efforts, such as local manufacturing, regulatory reliance, and strengthening the community health workforce and laboratory capacity in low- and middle-income countries (LMICs) cannot be more significant for ensuring sustainable and equitable access to diagnostic tools during pandemic.</p>","PeriodicalId":52405,"journal":{"name":"Global Health Research and Policy","volume":"8 1","pages":"45"},"PeriodicalIF":4.0,"publicationDate":"2023-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605783/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54232131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Belt and road initiative and healthy silk road: an alternative path for Pacific island countries to participate in global public health governance. “一带一路”倡议倡议与健康丝绸之路:太平洋岛国参与全球公共卫生治理的替代路径。
IF 8.7 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-10-19 DOI: 10.1186/s41256-023-00329-8
Yujie Mei

Pacific island countries (PICs) located in a region with relatively insufficient capacity to respond to public health emergencies, establishing reliable public health cooperation is conducive to maintaining security and stability. The belt and road initiative (BRI) launched by China attempts to provide a novel form of international cooperation and has supported multi-channel investment and construction. This article elucidates the history of public health cooperation between China and PICs, as well as the current situation of the BRI in the field of public health and emphasizes that there are numerous constraints in the public health cooperation between China and PICs. Given the profound impact of COVID-19 on diplomatic strategies, gradual cooperation in the field of public health may be the initial exploration of the BRI in the PICs, but it also means that the initiative must deal with challenges from geopolitical competition and cultural differences.

太平洋岛国位于应对突发公共卫生事件能力相对不足的地区,建立可靠的公共卫生合作有利于维护安全与稳定。中国提出的“一带一路”倡议为国际合作提供了新形式,支持了多渠道投资建设。本文阐述了中国与太平洋岛国公共卫生合作的历史,以及“一带一路”倡议在公共卫生领域的现状,并强调中国与太平洋国家公共卫生合作存在诸多制约因素。鉴于新冠肺炎对外交战略的深刻影响,公共卫生领域的逐步合作可能是“一带一路”倡议在PICs中的初步探索,但这也意味着该倡议必须应对地缘政治竞争和文化差异的挑战。
{"title":"Belt and road initiative and healthy silk road: an alternative path for Pacific island countries to participate in global public health governance.","authors":"Yujie Mei","doi":"10.1186/s41256-023-00329-8","DOIUrl":"10.1186/s41256-023-00329-8","url":null,"abstract":"<p><p>Pacific island countries (PICs) located in a region with relatively insufficient capacity to respond to public health emergencies, establishing reliable public health cooperation is conducive to maintaining security and stability. The belt and road initiative (BRI) launched by China attempts to provide a novel form of international cooperation and has supported multi-channel investment and construction. This article elucidates the history of public health cooperation between China and PICs, as well as the current situation of the BRI in the field of public health and emphasizes that there are numerous constraints in the public health cooperation between China and PICs. Given the profound impact of COVID-19 on diplomatic strategies, gradual cooperation in the field of public health may be the initial exploration of the BRI in the PICs, but it also means that the initiative must deal with challenges from geopolitical competition and cultural differences.</p>","PeriodicalId":52405,"journal":{"name":"Global Health Research and Policy","volume":"8 1","pages":"44"},"PeriodicalIF":8.7,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585897/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49684913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Depression and health-related quality of life of patients with type 2 diabetes attending tertiary level hospitals in Dhaka, Bangladesh. 孟加拉国达卡三级医院2型糖尿病患者的抑郁和健康相关生活质量。
IF 8.7 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-10-16 DOI: 10.1186/s41256-023-00328-9
Manish K Namdeo, Sarita Verma, Rajat Das Gupta, Rubana Islam, Shaila Nazneen, Lal B Rawal

Introduction: Type 2 diabetes mellitus (T2DM) and depression are closely linked. People with T2DM are at increased risk of developing depression and vice versa. T2DM and depression comorbid conditions adversely affect Health-Related Quality of Life (HRQOL) and management of T2DM. In this study, we assessed depression and HRQOL among patients with T2DM in Dhaka, Bangladesh.

Methods: A cross-sectional study was conducted in two tertiary-level hospitals in Dhaka, Bangladesh. Data were collected from 318 patients with T2DM. A set of standard tools, PHQ-9 (for assessing depression) and EuroQol-5D-5L (for assessing the HRQOL), were used. Statistical analyses, including Chi-square and Fisher's exact tests, Wilcoxon (Mann-Whitney), and Spearman's correlation coefficient tests, were performed using SPSS (v.20).

Results: The majority of the patients (58%) were females, with a mean age (standard deviation) of 52 ± 10 years, and 74% of patients lived in urban areas. The prevalence of depression was 62% (PHQ-9 score ≥ 5). Over three-quarters (76%) reported problems in the anxiety/ depression dimension of EQ-5D, followed by pain/discomfort (74%), mobility (40%), self-care (36%), and usual activities (33%). The depression and T2DM comorbid condition were associated with all the five dimensions of EQ-5D (χ2 statistics with df = 1 was 52.33, 51.13, 52.67, 21.61, 7.92 for mobility, self-care, usual activities, pain/discomfort, and anxiety/ depression dimensions respectively, p- < 0.01). The mean EQ-5D index (0.53 vs. 0.75) and the mean EQ-5D VAS (65 vs. 76) both showed lower values in T2DM patients with depression compared to T2DM patients without depression (Wilcoxon test, p- < 0.001).

Conclusions: We conclude that the majority of the patients with T2DM had comorbid conditions, and the HRQOL was negatively affected by comorbid depression in T2DM patients. This suggests the importance of timely screening, diagnosis, treatment, and follow-up of comorbid depression in T2DM patients to improve overall health and QOL.

引言:2型糖尿病(T2DM)与抑郁症密切相关。T2DM患者患抑郁症的风险增加,反之亦然。T2DM和抑郁症合并症对健康相关生活质量(HRQOL)和T2DM的管理产生不利影响。在这项研究中,我们评估了孟加拉国达卡T2DM患者的抑郁和HRQOL。方法:在孟加拉国达卡的两家三级医院进行横断面研究。数据收集自318例T2DM患者。使用了一套标准工具PHQ-9(用于评估抑郁症)和EuroQol-5D-5L(用于评估HRQOL)。使用SPSS(v.20)进行统计分析,包括卡方检验和Fisher精确检验、Wilcoxon(Mann-Whitney)和Spearman相关系数检验。结果:大多数患者(58%)为女性,平均年龄(标准差)为52岁 ± 10年,74%的患者生活在城市地区。抑郁症的患病率为62%(PHQ-9评分 ≥ 5) 。超过四分之三(76%)的人报告了EQ-5D的焦虑/抑郁方面的问题,其次是疼痛/不适(74%)、行动能力(40%)、自我照顾(36%)和日常活动(33%)。抑郁症和T2DM合并症与EQ-5D的所有五个维度相关(χ = 1在行动能力、自我照顾、日常活动、疼痛/不适和焦虑/抑郁维度上分别为52.33、51.13、52.67、21.61和7.92,p- 结论:我们得出的结论是,大多数T2DM患者都有合并症,并且T2DM患者的HRQOL受到合并症抑郁症的负面影响。这表明及时筛查、诊断、治疗和随访T2DM患者合并抑郁对改善整体健康和生活质量的重要性。
{"title":"Depression and health-related quality of life of patients with type 2 diabetes attending tertiary level hospitals in Dhaka, Bangladesh.","authors":"Manish K Namdeo, Sarita Verma, Rajat Das Gupta, Rubana Islam, Shaila Nazneen, Lal B Rawal","doi":"10.1186/s41256-023-00328-9","DOIUrl":"10.1186/s41256-023-00328-9","url":null,"abstract":"<p><strong>Introduction: </strong>Type 2 diabetes mellitus (T2DM) and depression are closely linked. People with T2DM are at increased risk of developing depression and vice versa. T2DM and depression comorbid conditions adversely affect Health-Related Quality of Life (HRQOL) and management of T2DM. In this study, we assessed depression and HRQOL among patients with T2DM in Dhaka, Bangladesh.</p><p><strong>Methods: </strong>A cross-sectional study was conducted in two tertiary-level hospitals in Dhaka, Bangladesh. Data were collected from 318 patients with T2DM. A set of standard tools, PHQ-9 (for assessing depression) and EuroQol-5D-5L (for assessing the HRQOL), were used. Statistical analyses, including Chi-square and Fisher's exact tests, Wilcoxon (Mann-Whitney), and Spearman's correlation coefficient tests, were performed using SPSS (v.20).</p><p><strong>Results: </strong>The majority of the patients (58%) were females, with a mean age (standard deviation) of 52 ± 10 years, and 74% of patients lived in urban areas. The prevalence of depression was 62% (PHQ-9 score ≥ 5). Over three-quarters (76%) reported problems in the anxiety/ depression dimension of EQ-5D, followed by pain/discomfort (74%), mobility (40%), self-care (36%), and usual activities (33%). The depression and T2DM comorbid condition were associated with all the five dimensions of EQ-5D (χ2 statistics with df = 1 was 52.33, 51.13, 52.67, 21.61, 7.92 for mobility, self-care, usual activities, pain/discomfort, and anxiety/ depression dimensions respectively, p- < 0.01). The mean EQ-5D index (0.53 vs. 0.75) and the mean EQ-5D VAS (65 vs. 76) both showed lower values in T2DM patients with depression compared to T2DM patients without depression (Wilcoxon test, p- < 0.001).</p><p><strong>Conclusions: </strong>We conclude that the majority of the patients with T2DM had comorbid conditions, and the HRQOL was negatively affected by comorbid depression in T2DM patients. This suggests the importance of timely screening, diagnosis, treatment, and follow-up of comorbid depression in T2DM patients to improve overall health and QOL.</p>","PeriodicalId":52405,"journal":{"name":"Global Health Research and Policy","volume":"8 1","pages":"43"},"PeriodicalIF":8.7,"publicationDate":"2023-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577997/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41240811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The development and application of a two-step surveillance process for Healthy China Initiative based on wide coverage interagency data. 基于广泛覆盖的跨部门数据的健康中国倡议两步监测流程的开发和应用。
IF 8.7 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-09-22 DOI: 10.1186/s41256-023-00326-x
Lin Liu, Xiaomeng Lan, Yili Yang, Yuying Luo, Xueli Zhang, Xiuli Wang, Jay Pan

Background: Healthy China is a nationwide health strategy aiming at improving health from diverse dimensions, and strengthening high-quality assessment is essential for its stimulation. However, there is limited evidence in the surveillance of the actual performance of the initiative at regional levels. This study innovatively proposes a two-step surveillance process which comprehensively monitors Healthy China Initiative based on regional realities, thus provides guidance for policymaking.

Methods: A flexible indicator system was firstly developed basing on Delphi survey and focus group discussions. And then the Analysis Hierarchical Process and the TOPSIS method were used to determine the weights of indicators and calculate comprehensive indexes as the surveillance outcomes. A pilot study was conducted in a typical area in China to verify the applicability of the process.

Results: Following the surveillance process and basing on the implementation of Healthy China Initiative in the target region, an indicator system comprised of 5 domains and 23 indicators with weights was first developed specifically for the pilot area. Then 1848 interagency data of the study area were collected from 8 provincial institutions/departments to calculate the indexes and ranks of the five domains which were health level, healthy living, disease prevention and control, health service, and healthy environment. The outcomes showed that Healthy China Initiative in the pilot area had been constantly improved since the strategy proposed, while there were still issues to be tackled such as the deficient monitoring mechanisms and unevenly development progress.

Conclusions: This study proposed a pragmatic surveillance process with indicators which could be tailored for specific context of target regions and produce meaningful surveillance outcomes to inform decision-making for policymakers, and also provided a theoretical foundation as well as empirical evidence for further health strategies and plannings assessment studies.

背景:健康中国是一项旨在从多个维度改善健康状况的全国性健康战略,加强高质量的评估对其激励至关重要。然而,在区域一级监督该倡议的实际执行情况的证据有限。本研究创新性地提出了一个分两步的监测过程,基于地区实际对健康中国倡议进行全面监测,从而为政策制定提供指导。方法:在德尔菲调查和焦点小组讨论的基础上,首次建立了一个灵活的指标体系。然后采用层次分析法和TOPSIS法确定指标权重,计算综合指标作为监测结果。在中国的一个典型地区进行了试点研究,以验证该过程的适用性。结果:遵循监测过程,在目标地区实施健康中国倡议的基础上,首次为试点地区制定了一个由5个领域和23个有权重指标组成的指标体系。然后,从8个省级机构/部门收集了1848份研究区域的跨部门数据,计算了健康水平、健康生活、疾病预防控制、卫生服务和健康环境五个领域的指标和排名。结果表明,自战略提出以来,试点地区的健康中国倡议不断完善,但仍存在监测机制不足、发展进度不均衡等问题需要解决。结论:本研究提出了一个务实的监测过程,其中的指标可以根据目标地区的具体情况进行定制,并产生有意义的监测结果,为决策者的决策提供信息,同时也为进一步的卫生战略和规划评估研究提供了理论基础和经验证据。
{"title":"The development and application of a two-step surveillance process for Healthy China Initiative based on wide coverage interagency data.","authors":"Lin Liu, Xiaomeng Lan, Yili Yang, Yuying Luo, Xueli Zhang, Xiuli Wang, Jay Pan","doi":"10.1186/s41256-023-00326-x","DOIUrl":"10.1186/s41256-023-00326-x","url":null,"abstract":"<p><strong>Background: </strong>Healthy China is a nationwide health strategy aiming at improving health from diverse dimensions, and strengthening high-quality assessment is essential for its stimulation. However, there is limited evidence in the surveillance of the actual performance of the initiative at regional levels. This study innovatively proposes a two-step surveillance process which comprehensively monitors Healthy China Initiative based on regional realities, thus provides guidance for policymaking.</p><p><strong>Methods: </strong>A flexible indicator system was firstly developed basing on Delphi survey and focus group discussions. And then the Analysis Hierarchical Process and the TOPSIS method were used to determine the weights of indicators and calculate comprehensive indexes as the surveillance outcomes. A pilot study was conducted in a typical area in China to verify the applicability of the process.</p><p><strong>Results: </strong>Following the surveillance process and basing on the implementation of Healthy China Initiative in the target region, an indicator system comprised of 5 domains and 23 indicators with weights was first developed specifically for the pilot area. Then 1848 interagency data of the study area were collected from 8 provincial institutions/departments to calculate the indexes and ranks of the five domains which were health level, healthy living, disease prevention and control, health service, and healthy environment. The outcomes showed that Healthy China Initiative in the pilot area had been constantly improved since the strategy proposed, while there were still issues to be tackled such as the deficient monitoring mechanisms and unevenly development progress.</p><p><strong>Conclusions: </strong>This study proposed a pragmatic surveillance process with indicators which could be tailored for specific context of target regions and produce meaningful surveillance outcomes to inform decision-making for policymakers, and also provided a theoretical foundation as well as empirical evidence for further health strategies and plannings assessment studies.</p>","PeriodicalId":52405,"journal":{"name":"Global Health Research and Policy","volume":"8 1","pages":"42"},"PeriodicalIF":8.7,"publicationDate":"2023-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515230/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41172068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Global Health Research and Policy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1